SUBMIT INQUIRY

Articles

Browse our regulatory articles below or search through our archive.

 


 

  • 5 QUESTIONS & ANSWERS: STRATEGIC REGULATORY PLANNING FOR YOUNG MEDTEC COMPANIES

    Posted on Nov 06, 2012
    An Interview with Arazy Group President & CEO Benjamin Arazy. 2013 will not be an easy year for MedTech. Last year, MedTec investments in the United States declined by 27% compared to 2011 and this trend is expected to continue. Funding from venture capital funds for this industry have been declining due to a back log of medical device companies seeking an "exit" in the next ten years. The main difficulty will be for startups in the early stages of... Continue reading
latest news
  • Oct 3 2018
    REGULATORY UPDATE - LABORIE

    China: Laborie's Aquarius System was approved for sale with LICENSALE.COM®. ...

    Read More
  • Sep 28 2018
    REGULATORY UPDATE - VAREX IMAGING CORP.

    Canada: Varex Imaging's Nexus DR was approved for sale with LICENSALE.COM®....

    Read More
  • Sep 12 2018
    REGULATORY UPDATE - TECHNOPATH CLINICAL DIAGNOSTICS

    Canada: Technopath Clinical Diagnostics' Multichem A1C was approved for sale with LICENSALE.COM®. ...

    Read More
  • Aug 16 2018
    REGULATORY UPDATE - VIASONIX

    Canada: Viasonix' Dolphin family of products was approved for sale with LICENSALE.COM®....

    Read More
  • Aug 8 2018
    REGULATORY UPDATE - ORASURE TECHNOLOGIES

    Nepal: OraSure Technologies' OraQuick HIV Self-Test was approved for sale with LICENSALE.COM®....

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP